Abstract

Zwitterionic polysaccharides (ZPs) have been shown in recent years to display peculiar immunological properties, thus attracting the interest of the carbohydrate research community. To fully elucidate the mechanisms underlying these properties and exploit the potential of this kind of structures, in depth studies are still required. In this context, the preparation of two cationic, an anionic, as well as two zwitterionic tetrasaccharide analogues of the smallest immunogenic structure of Streptococcus pneumoniae type 14 (SP14) capsular polysaccharide are presented. By exploiting a block strategy, the negative charge has been installed on the non-reducing end of the lactose unit of the tetrasaccharide and the positive charge either on the non-reducing end of the lactosamine moiety or on an external linker. These structures have then been tested by competitive ELISA, showing that the structural variations we made do not modify the affinity of the neutral compound to binding to a specific antibody. However, lower efficacies than the natural SP14 compound were observed. The results obtained, although promising, point to the need to further elongate the polysaccharide structure, which is likely too short to cover the entire epitopes.

Highlights

  • Vaccination represents one of public health’s most cost-effective interventions, deeply contributing to global health security and striving against antimicrobial resistance

  • These structures have been tested by competitive ELISA, showing that the structural variations we made do not modify the affinity of the neutral compound to binding to a specific antibody

  • Streptococcus pneumoniae type 14 (SP14) capsular polysaccharide (CPS) and all synthesized oligosaccharides are recognized by the antibody in a with a specific rabbit anti-SP14 polyclonal antibody showed that the natural SP14 CPS concentration-dependent manner

Read more

Summary

Introduction

Vaccination represents one of public health’s most cost-effective interventions, deeply contributing to global health security and striving against antimicrobial resistance In this context, carbohydrate-based vaccines have been studied and developed for many years [1,2,3,4]. These pathogen-specific glycan structures act as epitopes, able to elicit specific antibodies when in contact with the host immune cells, representing promising target structures for the development of vaccines. B-cell-mediated immune responses without IgG class switching and memory development [5] For this reason, the two polysaccharide vaccines currently on the market are both conjugated to an immunogenic carrier protein. ZPs, are able to beII), processed by the antigen presenting cells into the class-II major histocompatibility complex (MCH for presentation to T-cells and activation (APC). The introduction of charges or the zwitterionization influence the ability to bind to specific antibodies

Results anda Discussion
Chemistry
Preparation
Synthesis of the Target Tetrasaccharides 2–7
42–47. Reagents
Biological
Results of the Compound
General
General Procedure for the 6-O-glycosylation
Test ELISA
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call